These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33239302)

  • 21. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.
    Chang J; Paillard A; Passirani C; Morille M; Benoit JP; Betbeder D; Garcion E
    Pharm Res; 2012 Jun; 29(6):1495-505. PubMed ID: 22167349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Passive internalization and active extrusion determines PLGA-nanoparticle concentration in cancer cell lines.
    Baidya G; Tiwary R; Mudassir M; Singh N; Saha S; Chosdol K; Sinha S; Chattopadhyay P
    Nanomedicine (Lond); 2020 Aug; 15(23):2229-2239. PubMed ID: 32924855
    [No Abstract]   [Full Text] [Related]  

  • 23. Intranasal delivery of Paclitaxel encapsulated nanoparticles for brain injury due to Glioblastoma.
    Zhang Y; Sun C; Zhang Q; Deng Y; Hu X; Chen P
    J Appl Biomater Funct Mater; 2020; 18():2280800020977170. PubMed ID: 33307944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].
    Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP
    Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats.
    Sun D; Xue A; Zhang B; Lou H; Shi H; Zhang X
    J Pharm Pharmacol; 2015 Dec; 67(12):1650-62. PubMed ID: 26407669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems.
    Semete B; Booysen L; Lemmer Y; Kalombo L; Katata L; Verschoor J; Swai HS
    Nanomedicine; 2010 Oct; 6(5):662-71. PubMed ID: 20230912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular Targeting of Poly Lactic-Co-Glycolic Acid Nanoparticles by Surface Functionalization with Peptides.
    de Oliveira TD; Travassos LR; Arruda DC; Tada DB
    J Biomed Nanotechnol; 2021 Jul; 17(7):1320-1329. PubMed ID: 34446135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.
    Vandorpe J; Schacht E; Dunn S; Hawley A; Stolnik S; Davis SS; Garnett MC; Davies MC; Illum L
    Biomaterials; 1997 Sep; 18(17):1147-52. PubMed ID: 9259511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
    Srivastava S; Gupta S; Mohammad S; Ahmad I
    J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micelle-templated, poly(lactic-
    Nabar GM; Mahajan KD; Calhoun MA; Duong AD; Souva MS; Xu J; Czeisler C; Puduvalli VK; Otero JJ; Wyslouzil BE; Winter JO
    Int J Nanomedicine; 2018; 13():351-366. PubMed ID: 29391794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Highly Translatable Dual-arm Local Delivery Strategy To Achieve Widespread Therapeutic Coverage in Healthy and Tumor-bearing Brain Tissues.
    Negron K; Kwak G; Wang H; Li H; Huang YT; Chen SW; Tyler B; Eberhart CG; Hanes J; Suk JS
    Small; 2023 Mar; 19(11):e2207278. PubMed ID: 36651002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved oral delivery of insulin by PLGA nanoparticles coated with 5
    Wang W; Yu C; Zhang F; Li Y; Zhang B; Huang J; Zhang Z; Jin L
    Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34571498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced cellular uptake and biodistribution of a synthetic cannabinoid loaded in surface-modified poly(lactic-co-glycolic acid) nanoparticles.
    Durán-Lobato M; Muñoz-Rubio I; Holgado MA; Alvarez-Fuentes J; Fernández-Arévalo M; Martín-Banderas L
    J Biomed Nanotechnol; 2014 Jun; 10(6):1068-79. PubMed ID: 24749401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodistribution and toxicity of orally administered poly (lactic-co-glycolic) acid nanoparticles to F344 rats for 21 days.
    Navarro SM; Morgan TW; Astete CE; Stout RW; Coulon D; Mottram P; Sabliov CM
    Nanomedicine (Lond); 2016 Jul; 11(13):1653-69. PubMed ID: 27347781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain.
    Patel BK; Parikh RH; Patel N
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):97-100. PubMed ID: 29593405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
    J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier.
    Chaturvedi M; Molino Y; Sreedhar B; Khrestchatisky M; Kaczmarek L
    Int J Nanomedicine; 2014; 9():575-88. PubMed ID: 24531257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.